These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5626768)

  • 21. Separation of plasma thromboplastin antecedent (PTA) and Hageman factor (HF) from human plasma.
    SCHIFFMAN S; RAPAPORT SI; WARE AG; MEHL JW
    Proc Soc Exp Biol Med; 1960 Dec; 105():453-5. PubMed ID: 13747627
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the behavior of the Hageman factor and plasma thromboplastin antecedent (PTA) under the influence of hydroxycoumarin and phenylindanedione administration].
    RODERMUND OE; SCHNEIDER W; EGLI H
    Thromb Diath Haemorrh; 1961 Apr; 5():595-6. PubMed ID: 13742528
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies regarding the effect of foreign-surface contact on the one-stage prothrombin time determination.
    Shanberge JN; Matsuoka T
    Thromb Diath Haemorrh; 1966 May; 15(3):442-50. PubMed ID: 5989030
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hageman factor. Present-day views].
    Ratajczak T; Szewczyk Z
    Postepy Hig Med Dosw; 1978; 32(3):291-309. PubMed ID: 714825
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Jul; 102(1):31-45. PubMed ID: 6343536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The participation of plasma thromboplastin antecedent (Factor XI) in contact-activated fibrinolysis.
    Saito H
    Proc Soc Exp Biol Med; 1980 Jun; 164(2):153-7. PubMed ID: 6446720
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of chemical modification of basic amino acid residues on the activation and amidolytic activity of Hageman factor (factor XII).
    Ryder J; Everson B; Jentoft J; Ratnoff OD
    J Lab Clin Med; 1993 Dec; 122(6):697-702. PubMed ID: 8245689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of oxyphenbutazone on partial thromboplastin time and lack of effect on Hageman factor in guinea pigs.
    Weiner M
    J Med; 1971; 2(2):120-5. PubMed ID: 5286513
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of factor XI in thrombin generation induced by low concentrations of tissue factor.
    Keularts IM; Zivelin A; Seligsohn U; Hemker HC; Béguin S
    Thromb Haemost; 2001 Jun; 85(6):1060-5. PubMed ID: 11434685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hageman factor (factor XII) activity in synovial fluid of rheumatoid arthritis patients and its possible pathogenic significance.
    Szpilmanowa H; Stachurska J
    Experientia; 1968 Aug; 24(8):784-5. PubMed ID: 5683163
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of activated Hageman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor).
    Hedner U; Martinsson G
    Thromb Res; 1978 Jun; 12(6):1015-23. PubMed ID: 99837
    [No Abstract]   [Full Text] [Related]  

  • 33. Coagulation factor XIIa (activated Hageman factor) inhibitor from adult Schistosoma mansoni.
    Tsang VC; Hubbard WJ; Damian RT
    Am J Trop Med Hyg; 1977 Mar; 26(2):243-7. PubMed ID: 848647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of the Hageman factor (factor XII) with insoluble collagen.
    Niewiarowski S; Bańkowski E
    Bull Acad Pol Sci Biol; 1969; 17(3):137-9. PubMed ID: 5800063
    [No Abstract]   [Full Text] [Related]  

  • 35. Hageman factor: alterations in physical properties during activation.
    Donaldson VH; Ratnoff OD
    Science; 1965 Nov; 150(3697):754-6. PubMed ID: 5844078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activation of the coagulation and kinin system by a plasma esterase (Hageman factor): purification and conditions of activity].
    Temme H; Jahrreiss R; Habermann E; Zilliken F
    Hoppe Seylers Z Physiol Chem; 1969 Apr; 350(4):519-21. PubMed ID: 5798595
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of human polymorphonuclear leukocytes by purified human plasma kallikrein.
    Schapira M; Scott CF; Boxer LA; Colman RW
    Adv Exp Med Biol; 1983; 156 (Pt B)():747-53. PubMed ID: 6552863
    [No Abstract]   [Full Text] [Related]  

  • 38. The activation of PTA (factor XI) and Hageman factor (factor XII).
    Ratnoff OD; Botti RE; Crum JD; Donaldson VH
    Thromb Diath Haemorrh Suppl; 1965; 17():1-14. PubMed ID: 5335359
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Interactions between factors XII and XI and activating agents in purified systems.
    Binder B; Krug G; Vukovich T
    Thromb Diath Haemorrh; 1975 Sep; 34(1):354. PubMed ID: 1188805
    [No Abstract]   [Full Text] [Related]  

  • 40. The possible role of platelets in bypassing the contact phase of blood coagulation.
    Walsh PN; Tuszynski GP; Greengard JS; Griffin JH
    Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.